glp-1-based weight-loss drugs GLP-1 weight loss drug study finds small increase in risk of osteoporosis and gout Study finds GLP-1 receptor agonists

The aspects of artificial intelligence in different phases of the food value and supply chain

Almost 30% of the events were reported by nonmedically trained individuals, which may affect the diagnostic accuracy of these findings

The current level considered sufficient for folate in plasma (i.e

Topical vs Injectable Tolerability Topical GHK-Cu appears better tolerated than injectable forms, with topical side effects typically limited to mild redness, itching, or irritation at application site and rare copper uglies phenomenon (anecdotal accelerated skin aging appearance due to potential MMP upregulation, not well-studied)

14 : 107115 De Falco FA, D'Angelo E, Grimaldi G, Scafuro F, Sachez F, Caruso G